Abstract

A central event in the development of the allergic response is the interaction between immunoglobulin E (IgE) and its cellular high-affinity receptor FcεRI. Allergen-bound IgE mediates the allergic response by binding through its Fc region to its cellular receptor on mast cells and basophils, causing the release of chemical mediators. One strategy for the treatment of allergic disorders is the use of therapeutic compounds which would inhibit the interaction between IgE and FcεRI. Using a structure-based design approach, conformationally constrained synthetic peptides were designed to mimic a biologically active β-hairpin region of the α-chain of FcεRI. Two peptide mimics of the FcεRI α-chain were previously shown to inhibit IgE−FcεRI interactions, one a peptide comprised of l-amino acids, covalently cyclized by N- and C-terminal cysteine residues, and the other its retroenantiomer. In this paper the solution structures of these compounds are derived using NMR spectroscopy. The topochemical relationship between the retroenantiomeric compounds and the structural basis of their biological activity is described.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.